Key result
The transition from cardiac hypertrophy to heart failure is mediated by complex molecular mechanisms including cardiac myocyte loss, abnormalities of calcium handling, and myocardial ischemia/hypoxia.
Design
Review
Authors
Loading...
Progress in hypertrophy mechanisms has enabled effective therapies; leaves open precise targets needed to lower persistent heart failure mortality.
Understanding the molecular mechanisms of cardiac myocyte loss, calcium handling abnormalities, and ischemia/hypoxia is crucial for developing novel therapies to prevent the transition from cardiac hypertrophy to heart failure.
Oka et al. (2008) conducted a review in Heart failure and cardiac hypertrophy. The transition from cardiac hypertrophy to heart failure is mediated by complex molecular mechanisms including cardiac myocyte loss, abnormalities of calcium handling, and myocardial ischemia/hypoxia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: